India invites proposals under PRIP scheme to propel Pharma‑MedTech R&D projects

FDA Approves First Generic Mifepristone, Takeda Exits Cell Therapy Research, and SciSafe Expands Biopharma Storage

DRRA29 minutes ago 0

Eli Lilly to invest over $1 billion in contract manufacturing in India

DRRA48 minutes ago 0

Immune reset: How T cell engagers can change the autoimmune treatment landscape

DRRA1 hour ago 0

Delayed TNBC readout for Datroway delivers survival benefit

DRRA2 hours ago 0